98 related articles for article (PubMed ID: 16433039)
1. Cinnamylidene ketones as potential modulators of multidrug resistance in mouse lymphoma and human colon cancer cell lines.
Engi H; Gyémánt N; Lóránd T; Lévai A; Ocsovszki I; Molnár J
In Vivo; 2006; 20(1):119-24. PubMed ID: 16433039
[TBL] [Abstract][Full Text] [Related]
2. New silicon compounds as resistance modifiers against multidrug-resistant cancer cells.
Molnar J; Mucsi I; Nacsa J; Hevér A; Gyémánt N; Ugocsai K; Hegyes P; Kiessig S; Gaal D; Lage H; Varga A
Anticancer Res; 2004; 24(2B):865-71. PubMed ID: 15161039
[TBL] [Abstract][Full Text] [Related]
3. Development of rational in vitro models for drug resistance in breast cancer and modulation of MDR by selected compounds.
Kars MD; Iseri OD; Gündüz U; Ural AU; Arpaci F; Molnár J
Anticancer Res; 2006; 26(6B):4559-68. PubMed ID: 17201178
[TBL] [Abstract][Full Text] [Related]
4. Toxoplasma infection and cell free extract of the parasites are able to reverse multidrug resistance of mouse lymphoma and human gastric cancer cells in vitro.
Varga A; Sokolowska-Kohler W; Presber W; Von Baehr V; Von Baehr R; Lucius R; Volk D; Nacsa J; Hever A
Anticancer Res; 1999; 19(2A):1317-24. PubMed ID: 10368693
[TBL] [Abstract][Full Text] [Related]
5. Multidrug resistance reversal by 3-formylchromones in human colon cancer and human mdr1 gene-transfected mouse lymphoma cells.
Baráth Z; Radics R; Spengler G; Ocsovszki I; Kawase M; Motohashi N; Shirataki Y; Shah A; Molnár J
In Vivo; 2006; 20(5):645-9. PubMed ID: 17091772
[TBL] [Abstract][Full Text] [Related]
6. Reversal of multidrug resistance of cancer cells in vitro: modification of drug resistance by selected carotenoids.
Gyémánt N; Tanaka M; Molnár P; Deli J; Mándoky L; Molnár J
Anticancer Res; 2006; 26(1A):367-74. PubMed ID: 16475720
[TBL] [Abstract][Full Text] [Related]
7. Preliminary studies on phenothiazine-mediated reversal of multidrug resistance in mouse lymphoma and COLO 320 cells.
Pajak B; Molnar J; Engi H; Orzechowski A
In Vivo; 2005; 19(6):1101-4. PubMed ID: 16277030
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of anticancer effects of newly synthesized dihydropyridine derivatives in comparison to verapamil and doxorubicin on T47D parental and resistant cell lines in vitro.
Bazargan L; Fouladdel S; Shafiee A; Amini M; Ghaffari SM; Azizi E
Cell Biol Toxicol; 2008 Apr; 24(2):165-74. PubMed ID: 17805981
[TBL] [Abstract][Full Text] [Related]
9. MDR-reversal activity of chalcones.
Ivanova A; Batovska D; Engi H; Parushev S; Ocsovszki I; Kostova I; Molnar J
In Vivo; 2008; 22(3):379-84. PubMed ID: 18610751
[TBL] [Abstract][Full Text] [Related]
10. A search for multidrug resistance modulators: the effects of retinoids in human colon carcinoma cells.
Bartolini G; Orlandi M; Papi A; Ammar K; Guerra F; Ferreri AM; Rocchi P
In Vivo; 2006; 20(6A):729-33. PubMed ID: 17203756
[TBL] [Abstract][Full Text] [Related]
11. In vitro search for synergy between flavonoids and epirubicin on multidrug-resistant cancer cells.
Gyémánt N; Tanaka M; Antus S; Hohmann J; Csuka O; Mándoky L; Molnár J
In Vivo; 2005; 19(2):367-74. PubMed ID: 15796199
[TBL] [Abstract][Full Text] [Related]
12. Effect of pO2 on antitumor drug cytotoxicity on MDR and non-MDR variants selected from the LoVo metastatic colon carcinoma cell line.
Lelong-Rebel I; Brisson C; Fabre M; Bergerat JP; Rebel G
Anticancer Res; 2008; 28(1A):55-68. PubMed ID: 18383825
[TBL] [Abstract][Full Text] [Related]
13. Reversal of multidrug resistance by synthetic and natural compounds in drug-resistant MCF-7 cell lines.
Kars MD; Işeri OD; Gunduz U; Molnar J
Chemotherapy; 2008; 54(3):194-200. PubMed ID: 18560226
[TBL] [Abstract][Full Text] [Related]
14. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
Wang TX; Yang XH
Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331
[TBL] [Abstract][Full Text] [Related]
15. New MDR modulators and apoptosis inducers from Euphorbia species.
Engi H; Vasas A; Rédei D; Molnár J; Hohmann J
Anticancer Res; 2007; 27(5A):3451-8. PubMed ID: 17970094
[TBL] [Abstract][Full Text] [Related]
16. Tumour-specific cytotoxicity and MDR-reversal activity of dihydropyridines.
Engi H; Sakagami H; Kawase M; Parecha A; Manvar D; Kothari H; Adlakha P; Shah A; Motohashi N; Ocsovszki I; Molnár J
In Vivo; 2006; 20(5):637-43. PubMed ID: 17091771
[TBL] [Abstract][Full Text] [Related]
17. Induction of apoptosis and necrosis by resistance modifiers benzazoles and benzoxazines on tumour cell line mouse lymphoma L5718 Mdr+cells.
Varga A; Aki-Sener E; Yalcin I; Temiz-Arpaci O; Tekiner-Gulbas B; Cherepnev G; Molnar J
In Vivo; 2005; 19(6):1087-91. PubMed ID: 16277027
[TBL] [Abstract][Full Text] [Related]
18. Modulation of multidrug resistance and apoptosis of cancer cells by selected carotenoids.
Molnár J; Gyémánt N; Mucsi I; Molnár A; Szabó M; Körtvélyesi T; Varga A; Molnár P; Tóth G
In Vivo; 2004; 18(2):237-44. PubMed ID: 15113052
[TBL] [Abstract][Full Text] [Related]
19. Multidrug resistance reversal in mouse lymphoma cells by heterocyclic compounds.
Molnár J; Szabo D; Mándi Y; Mucsi I; Fischer J; Varga A; König S; Motohashi N
Anticancer Res; 1998; 18(4C):3033-8. PubMed ID: 9713505
[TBL] [Abstract][Full Text] [Related]
20. Effects of selected flavonoids and carotenoids on drug accumulation and apoptosis induction in multidrug-resistant colon cancer cells expressing MDR1/LRP.
Ugocsai K; Varga A; Molnár P; Antus S; Molnár J
In Vivo; 2005; 19(2):433-8. PubMed ID: 15796208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
